#Luspatercept hashtag - Bluesky

@hemehub.bsky.social

2 weeks ago

🩸🩺Today’s questions!

Swipe to see the answers and their explanations!

#Myelofibrosis #MDS #Hematology #MedEd #BloodDisorders #Luspatercept #Imetelstat #Navtemadlin #Pelabresib #Anemia #HEMEHUB

0 0 0 0

@hemehub.bsky.social

3 weeks ago

🩸 Additional insights on combination & emerging therapies in Myelofibrosis

#Myelofibrosis #HemeOnc #Hematology #MedEd #ClinicalTrials #HEMEHUB #Luspatercept #PIM1 #Nuvisertib #TP3654 #Ruxolitinib #Momelotinib #Imetelstat #TregTherapy #Immunotherapy

0 0 0 0

Signal Transduction and Targeted Therapy

@sigtrans-sttt.bsky.social

5 months ago

#TGFβ1 drives maladaptive #BoneMarrow (BM) endothelial cells (ECs), impairing #vascular regeneration and #hematopoietic support via a #secretome shift, while #TGFβ1 inhibition or #Luspatercept restores BM EC function. @pku1898.bsky.social #medsky

#STTT: doi.org/10.1038/s413...

1 0 0 0

Rare Disease Advisor

@rarediseaseadvisor.bsky.social

6 months ago

Luspatercept May Achieve Transfusion Independence in Lower-Risk MDS Luspatercept induced 8-week transfusion independence in over half of patients with lower-risk myelodysplastic syndromes (MDS), a study found.

#Luspatercept was effective and well-tolerated for management of #Anemia in transfusion-dependent lower-risk #MyelodysplasticSyndromes (LR-MDS), with the strongest responses observed in patients who were RS⁺ or had a low transfusion burden @bloodadvances.bsky.social

Read: https://bit.ly/46HlokT

0 0 0 0